EVOK

Evoke Pharma (EVOK)

Evoke Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EVOK

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/07	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/31	07 : 09	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/25	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/25	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/25	05 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/17	05 : 02	GlobeNewswire Inc.	Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 58	Edgar (US Regulatory)	Form ARS/A - Annual Report to Security Holders: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 15	GlobeNewswire Inc.	Evoke Pharma Reports First Quarter 2024 Financial Results	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 05	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/05/15	05 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/04/17	21 : 30	GlobeNewswire Inc.	Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/22	05 : 15	GlobeNewswire Inc.	Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/15	05 : 05	GlobeNewswire Inc.	Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:EVOK	Evoke Pharma Inc
2024/03/08	06 : 10	GlobeNewswire Inc.	Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/24	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/21	06 : 38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/14	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/14	21 : 30	GlobeNewswire Inc.	Evoke Pharma Announces Closing of $7.5 Million Public Offering	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/10	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/10	07 : 14	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/09	21 : 30	GlobeNewswire Inc.	Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/09	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EVOK	Evoke Pharma Inc
2024/02/08	20 : 50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/01/11	11 : 38	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2024/01/05	06 : 30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/12/19	22 : 30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/12/16	06 : 30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:EVOK	Evoke Pharma Inc
2023/11/29	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVOK	Evoke Pharma Inc